Humana’s monopolisation suit against Mallinckrodt moves forward
Humana has sufficiently alleged that Mallinckrodt illegally maintained a monopoly over treatment for infant seizures by purchasing rights to a potential substitute, a California federal court has ruled.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10